Skip to main content
OpenTrials

Clinical trial condition

DLBCL

Explore clinical trials studying DLBCL. Study availability and eligibility vary by location and protocol.

51 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

DLBCL trial results

Recruiting

A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)

NCT05487170

Conditions
Advanced Solid Tumor, DLBCL
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Weill Cornell - NY Presbyterian Hospital New York, United States
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
View Trial Details
Recruiting

A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

NCT04332822

Conditions
DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations
  • Border Medical Oncology Research Unit Albury, Australia
  • Royal Prince Alfred Hospital Camperdown, Australia
  • Coffs Harbour Coffs Harbour, Australia
  • Concord Repatriation General Hospital Concord, Australia
View all 69 locations
View Trial Details
Recruiting

Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT06521255

Conditions
DLBCL
Locations
  • Beijing Hospital Beijing, China
  • The First Hospital Of Jilin University Changchun, China
  • Hunan Cancer Hospital Changsha, China
  • Chenzhou No.1 People's Hospital Chaozhou, China
View all 20 locations
View Trial Details

Related conditions